Job Description
General/Position Summary
The Tax Department is responsible for global tax accounting, tax compliance, and tax planning for the Company. The International Senior Tax Analyst, reporting to the Senior Tax Director – International, will assist with the preparation/review of direct and indirect tax compliance and reporting for all countries outside North America, working closely with both the direct and indirect tax managers. The role will require a good grasp of financial data and working collaboratively with cross-functional team members, particularly finance.
Key Duties & Responsibilities
- Supports team in compiling and analysing financial data for direct and indirect compliance
- Proactively , through training and on-the-job learning, develops a deeper understanding of VAT and direct tax systems in key International jurisdictions
- Assists in review and reconciliation of month end tax balances (including use of BlackLine) and monthly/annual tax returns
- Supports treasury processes through management of related tax compliance
Required Education Level
Bachelor’s Degree in Accounting or equivalent, or alternatively ACA/CTA (or equivalent).
Required Experience
Extensive experience in Top 10/corporate in-house tax department or the equivalent combination of education and experience.
Required Knowledge/Skills
• Working knowledge of Excel
• Oracle
• Knowledge of OneSource Tax Provision and OneSource Income Tax
• Prior corporate Accounting/Tax office experience is a strong plus but not required
• Experience with Alteryx and/or Power BI is an advantage, but not essential
#LI-Hybrid
Flex Designation:
Hybrid-Eligible Or On-Site Eligible
Flex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected]
Top Skills
What We Do
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.
We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development.
Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
